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Background
Allergic asthma is a T helper type 2 (Th2)-dominated dis-
ease of the lung. In people with asthma, a fraction of CD4-
positive T cells express the CX3CL1 receptor, CX3CR1,
and CX3CL1 expression is increased in airway smooth
muscle, lung endothelium and epithelium upon allergen
challenge. In this study, we have investigated the role of
CX3CR1/CX3CL1 in the development of allergic asthma
in mice.
Results
We found that untreated CX3CR1-deficient mice or wild-
type mice treated with CX3CR1-blocking reagents showed
reduced lung disease upon allergen sensitization and chal-
lenge [1]. Transfer of wild-type CD4-positive T cells into
CX3CR1-deficient mice restored the cardinal features of
asthma, and CX3CR1-blocking reagents prevented airway
inflammation in CX3CR1-deficient recipients injected
with wild-type Th2 cells. We found that CX3CR1 signal-
ing promoted Th2 survival in the inflamed lungs, and
injection of B cell leukemia/lymphoma-2 protein (BCl-2)-
transduced CX3CR1-deficient Th2 cells into CX3CR1-
deficient mice restored asthma. CX3CR1-induced survival
was also observed for Th1 cells upon airway inflammation
but not under homeostatic conditions or upon peripheral
inflammation.
Conclusion
CX3CR1/CX3CL1 play a critical role in the development
of allergic asthma in mice making that these molecules
attractive therapeutic targets in asthma.
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